Diagnostic Microbiology and Infectious Disease · 2023 · 38 citations · 12 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibiotic ResistanceBacterial EpidemiologyBacterial InfectionsCarbapenem ResistanceMultidrug ResistancePathogen DetectionBroth MicrodilutionCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenem-resistant EnterobacteralesCarbapenemase EnzymesEnterobacterales ResistanceMultidrug-resistant OrganismsWhole-genome Sequencing Analysis
A total of 35,360 Enterobacterales isolates were consecutively collected from 75 US medical centers in 2018-2022. Among these isolates, 2612 (7.4%) were categorized as multidrug-resistant (MDR). Isolates were susceptibility tested by reference broth microdilution methods. Carbapenem-resistant Enterobacterales (CRE) were screened for carbapenemase (CPE) genes by whole genome sequencing. The highest MDR rates was observed among Klebsiella pneumoniae (12.2%), followed by Raoultella spp. (10.9%) and Providencia stuartii (9.8%). Ceftazidime-avibactam and meropenem-vaborbactam were very active and showed identical susceptibility rates against MDR isolates (97.9%). Imipenem-relebactam (93.5% susceptible [S]) exhibited slightly lower susceptibility rates due to its limited activity against Morganellaceae family. The most active β-lactamase inhibitor combination (BLI) against CRE isolates (n = 310) was ceftazidime-avibactam (84.2%S), followed by meropenem-vaborbactam (81.9%S) and imipenem-relebactam (74.8%S). All 3 BLIs were very active against KPC producers and none were active against MBL producers. Ceftazidime-avibactam exhibited greater activity against OXA-48-type producers than meropenem-vaborbactam and imipenem-vaborbactam.
12
Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al. · Clinical Microbiology and Infection · 2011 · 14K citations
Alessandro Cassini, Liselotte Diaz Högberg, Diamantis Plachouras et al. · The Lancet Infectious Diseases · 2018 · 3K citations · Full text
Veterinary Medicine, Health Sciences, Infectious Diseases +17
Vital signs: carbapenem-resistant Enterobacteriaceae.
Jesse T. Jacob, Eili Klein, Ramanan Laxminarayan et al. · PubMed Central · 2013 · 509 citations
Marco Falcone, Matteo Bassetti, Giusy Tiseo et al. · Critical Care · 2020 · 234 citations · Full text
Ghady Haidar, Cornelius J. Clancy, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2017 · 144 citations · Full text